Literature DB >> 33030752

Assessment of Tractable Cysteines for Covalent Targeting by Screening Covalent Fragments.

László Petri1, Péter Ábrányi-Balogh1, Imre Tímea2, Gyula Pálfy3, András Perczel3, Damijan Knez4, Martina Hrast4, Martina Gobec4, Izidor Sosič4, Kinga Nyíri5, Beáta G Vértessy5,6, Niklas Jänsch7, Charlotte Desczyk7, Franz-Josef Meyer-Almes7, Iza Ogris8, Simona Golič Grdadolnik8, Luca Giacinto Iacovino9, Claudia Binda9, Stanislav Gobec4, György M Keserű1.   

Abstract

Targeted covalent inhibition and the use of irreversible chemical probes are important strategies in chemical biology and drug discovery. To date, the availability and reactivity of cysteine residues amenable for covalent targeting have been evaluated by proteomic and computational tools. Herein, we present a toolbox of fragments containing a 3,5-bis(trifluoromethyl)phenyl core that was equipped with chemically diverse electrophilic warheads showing a range of reactivities. We characterized the library members for their reactivity, aqueous stability and specificity for nucleophilic amino acids. By screening this library against a set of enzymes amenable for covalent inhibition, we showed that this approach experimentally characterized the accessibility and reactivity of targeted cysteines. Interesting covalent fragment hits were obtained for all investigated cysteine-containing enzymes.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  KRASG12C; MAO; drug design; electrophilic warheads; targeted covalent inhibitors

Year:  2020        PMID: 33030752     DOI: 10.1002/cbic.202000700

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  3 in total

1.  Chemical proteomic identification of functional cysteines with atypical electrophile reactivities.

Authors:  Kevin Litwin; Vincent M Crowley; Radu M Suciu; Dale L Boger; Benjamin F Cravatt
Journal:  Tetrahedron Lett       Date:  2021-02-04       Impact factor: 2.415

Review 2.  Advances in UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) Covalent Inhibition.

Authors:  Maycon Vinicius Damasceno de Oliveira; Renan Machado Furtado; Kauê S da Costa; Serhii Vakal; Anderson H Lima
Journal:  Front Mol Biosci       Date:  2022-07-20

3.  Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads.

Authors:  Levente Kollár; Martina Gobec; Matic Proj; Lara Smrdel; Damijan Knez; Tímea Imre; Ágnes Gömöry; László Petri; Péter Ábrányi-Balogh; Dorottya Csányi; György G Ferenczy; Stanislav Gobec; Izidor Sosič; György M Keserű
Journal:  Cells       Date:  2021-12-06       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.